title: When first line therapy for AA-amyloidosis secondary to rheumatoid arthritis fails: a correspondence.
authors.forename: Jarred
authors.initials: J
authors.lastname: Burkart
authors.forename: Don Michael
authors.initials: DM
authors.lastname: Benson
mesh_terms: D000686:Amyloidosis / Q000097:blood / Q000188:drug therapy* / Q000209:etiology*; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D000069283:Rituximab; D000685:Serum Amyloid A Protein / Q000378:metabolism; D017211:Treatment Failure; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000685:Serum Amyloid A Protein; D014409:Tumor Necrosis Factor-alpha; D000069283:Rituximab